MIRA Pharmaceuticals Provides Corporate Update
Announces Research Collaboration with Pharmaseed to Conduct Pre-Clinical Studies on the Use of Ketamir for Patients with Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD)
Related news for (MIRA)
- Molecules, Machines & Markets: Biotech Booms, AI Accelerates, and Pain Relief Gets Personal
- Today’s Top Performers: MoBot’s Market Review 10/16/25 06:00 AM
- Breaking News: MoBot’s Latest Update as of 10/16/25 05:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 10/15/25 04:00 PM
- MoBot alert highlights: NASDAQ: CAN, NASDAQ: PMN, NASDAQ: MIRA, NASDAQ: SONN, NASDAQ: HUBC (07/14/25 09:00 AM)
